U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784881) titled 'Deciphering the Self Antigen Specific T Cell Signature of Autoimmune Liver Diseases' on Aug. 20.
Brief Summary: The study aim to establish the molecular signature of autoimmune self-antigen-specific T celles in AutoImmune Liver Disease (AILD)
Study Start Date: Aug., 2026
Study Type: OBSERVATIONAL
Condition:
Autoimmune Hepatitis
Primary Biliary Cholangitis (PBC)
Autoimmune Liver Disease
Primary Sclerosing Cholangitis (PSC)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nantes University Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....